Plant Advanced Technologies SA (EPA:ALPAT)
3.900
-0.340 (-8.02%)
Oct 2, 2026, 2:09 PM CET
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €4.38 million as of October 2, 2026. Its market cap has decreased by -53.93% in one year.
Market Cap
4.38M
Enterprise Value
8.30M
Revenue
1.37M
Ranking
n/a
PE Ratio
7.65
Stock Price
€3.90
ChartMarket Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has decreased from 6.22M to 4.38M, a decrease of -29.52%. That is a compound annual growth rate of -2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.38M | -52.34% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 20.49M |
| MaaT Pharma | 19.41M |
| Biophytis | 16.56M |
| Aelis Farma | 12.02M |
| Advicenne | 9.75M |
| TME Pharma | 9.73M |
| Aton | 9.61M |
| Poxel | 8.94M |